Thermanostics

AI-powered Thermal Imaging Device for Patient Screening

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in July 2020 by Yaniv Goldstein and Alona Goldstein, Thermanostics operates with 1–10 employees. The company graduated from the AtoBe Startup Accelerator program in June 2020.

Business overview

Thermanostics develops an AI-powered thermal imaging device aimed at enhancing patient screening efficiency and reducing unnecessary medical procedures. The company's core technology identifies neurogenic spots in the palm of the hand, which are associated with stressed organs, to pinpoint underlying causes rather than just symptoms. Thermanostics operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and medical device markets, with a focus on healthcare providers.

Log in to access full profile

Company Intelligence Q&A

When was Thermanostics founded and by whom?
Thermanostics was founded in July 2020 by co-founders Yaniv Goldstein and Alona Goldstein.
What is Thermanostics' primary product or technology?
Thermanostics' primary product is an AI-powered thermal imaging device designed to detect neurogenic spots in the palm of the hand, which are indicative of stressed organs, to identify underlying health issues.
Which accelerator program did Thermanostics participate in?
Thermanostics participated in the AtoBe Startup Accelerator program, from which it graduated in June 2020.
What problem does Thermanostics aim to solve?
Thermanostics aims to make patient screening more efficient and eliminate unnecessary tests and procedures by focusing on detecting underlying causes of health issues rather than just symptoms, thereby saving time, money, and lives.
What is the current stage of Thermanostics' product development?
Thermanostics' product is currently in the R&D stage, as of its last update in July 2021, and is classified as Pre-Funding.
Log in to access full profile